Description
Contents: 40 Kits – Each kit contains: 25 Test devices in sealed aluminum foil pouch with desiccant, 25 Empty reagent tubes, 25 Ampules containing extraction buffer (0.3mL), 25 Sample collection swabs, 1 Positive control swab, 1 Negative control swab, 1 Instructions for Use, 1 Quick Reference Instruction
Regulatory Status: FDA 510(k) Cleared, CLIA Waived
Determinations: Detection of the SARS-CoV-2 nucleocapsid protein antigen
Processing Time: 10 Minutes
The Nano-Check Influenza+COVID-19 Dual Test is a lateral flow immunochromatographic assay intended for in vitro rapid, simultaneous qualitative detection and differentiation of influenza A, and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly from anterior nasal swab specimens of individuals with signs and symptoms of respiratory infection consistent with COVID-19 within the first five (5) days of symptom onset when tested at least twice over three days with at least 48 hours between tests. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar.
Product Resources:
